(Q72573925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Hepatitis B, hepatocellular carcinoma, and strategies for prevention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

M. J. Arthur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142315

13 August 2023

A. J. Hall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142315

13 August 2023

R. Wright

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142315

13 August 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

17 March 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6142315

full work available at URL

13 August 2023

https://api.elsevier.com/content/article/PII:S0140673684910067?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91006-7

https://api.elsevier.com/content/article/PII:S0140673684910067?httpAccept=text/plain

13 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91006-7

13 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

607-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

State of hepatitis B viral DNA in a human hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Integration of hepatitis B virus sequences and their expression in a human hepatoma cell

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Integration of HBV-DNA into liver and hepatocellular carcinoma cells during persistent HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Three recently described animal virus models for human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Occurrence of cirrhosis and primary liver cancer in an Eskimo population hyperendemically infected with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Cirrhosis and hepatoma in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Hepatoma in an HBsAg carrier--seven years after perinatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Hepatitis B polypeptide vaccine preparation in micelle form

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Building new vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Hybrid vaccinia virus for mass hepatitis immunization?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Priorities for immunisation against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Hepatitis B virus infection in two Gambian villages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Outside Europe. Is poliomyelitis a serious problem in developing countries?--the Danfa experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2991006-7

7 January 2021

Epidemiology of primary liver cancer

4

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91006-7

Hepatitis B Virus Infection and Primary Hepatocellular Carcinoma 2 3

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)91006-7

13 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6142315%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference